Lyric Bio, Inc. has secured $6.6 million in seed financing, led by The Venture Collective, to advance its innovative biomanufacturing of donor-derived therapeutics.
Amount Raised
$6.6 Million
Round Type
Seed
San CarlosManufacturingBiotechnologyHealth CareInvestors
Description
Lyric Bio, Inc., a biomanufacturing startup, has closed an oversubscribed $6.6 million seed financing. The funding was led by The Venture Collective with participation from notable investors. The company aims to revolutionize donor-derived therapeutics with its advanced biomanufacturing platform. This funding will allow Lyric to improve efficiency and affordability in producing human immunoglobulin.
Quick answer
Lyric Bio raised $6.6 Million in a Seed round, dated December 2, 2025. Investors: Sosv, Meiji Seika Pharma, Black Diamond Ventures, Draper Associates, Lucas Venture Group and The Venture Collective. Lyric Bio is based in San Carlos, California, United States.
- How much did Lyric Bio raise?
- Lyric Bio raised $6.6 Million in a Seed round on December 2, 2025.
- Who invested in Lyric Bio?
- Sosv, Meiji Seika Pharma, Black Diamond Ventures, Draper Associates, Lucas Venture Group and The Venture Collective are named as investors in this round.
- What does Lyric Bio do?
- Lyric Bio, Inc. is dedicated to building next-generation manufacturing for donor-derived and protein-based therapeutics, with initial focus on immunoglobulin production.
- Where is Lyric Bio based and how big is it?
- Lyric Bio is based in San Carlos, California, United States. Fundz records about 7 employees.
- Who are the decision-makers at Lyric Bio?
- Fundz holds 1 contact at Lyric Bio, including the Co-Founder and CSO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Lyric Bio that raised within 45 days of this round, from Fundz verified event records.
- Novabay raised $134M on January 16, 2026.
- Conavi Medical raised $700K (Seed) on January 13, 2026.
- Route 92 Medical raised $50M on January 13, 2026.
- Surgerii Robotics raised $100M (Series D) on January 7, 2026.
- Harvard Apparatus Regenerative Technology raised $700K on December 30, 2025.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
Who to call at Lyric Bio, and when
A new round usually means Lyric Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lyric Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lyric Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lyric Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lyric Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lyric Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.